Literature DB >> 35172149

Histone marks regulate the epithelial-to-mesenchymal transition via alternative splicing.

Alexandre Segelle1, Yaiza Núñez-Álvarez1, Andrew J Oldfield1, Kimberly M Webb2, Philipp Voigt2, Reini F Luco3.   

Abstract

Histone modifications impact final splicing decisions. However, there is little evidence of the driving role of these marks in inducing cell-specific splicing changes. Using CRISPR epigenome editing tools, we show in an epithelial-to-mesenchymal cell reprogramming system (epithelial-to-mesenchymal transition [EMT]) that a single change in H3K27ac or H3K27me3 levels right at the alternatively spliced exon is necessary and sufficient to induce a splicing change capable of recapitulating important aspects of EMT, such as cell motility and invasiveness. This histone-mark-dependent splicing effect is highly dynamic and mediated by direct recruitment of the splicing regulator PTB to its RNA binding sites. These results support a role for H3K27 marks in inducing a change in the cell's phenotype via regulation of alternative splicing. We propose the dynamic nature of chromatin as a rapid and reversible mechanism to coordinate the splicing response to cell-extrinsic cues, such as induction of EMT. Crown
Copyright © 2022. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CRISPR; EMT; H3K27; alternative splicing; chromatin; epigenome editing; epithelial-to-mesenchymal transition; histone modifications

Mesh:

Substances:

Year:  2022        PMID: 35172149     DOI: 10.1016/j.celrep.2022.110357

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  3 in total

Review 1.  The physiology of alternative splicing.

Authors:  Luciano E Marasco; Alberto R Kornblihtt
Journal:  Nat Rev Mol Cell Biol       Date:  2022-10-13       Impact factor: 113.915

Review 2.  Histone Marks-Dependent Effect on Alternative Splicing: New Perspectives for Targeted Splicing Modulation in Cancer?

Authors:  Carol Imbriano; Silvia Belluti
Journal:  Int J Mol Sci       Date:  2022-07-27       Impact factor: 6.208

Review 3.  Epigenetics and environment in breast cancer: New paradigms for anti-cancer therapies.

Authors:  Chitra Thakur; Yiran Qiu; Yao Fu; Zhuoyue Bi; Wenxuan Zhang; Haoyan Ji; Fei Chen
Journal:  Front Oncol       Date:  2022-09-15       Impact factor: 5.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.